Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus and Sunitinib in Advanced RCC
NCT00417677Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus, sunitinib in renal cell carcinoma (RCC), sponsored by Pfizer. Started Mar 2007; status: terminated.
02
Drugs
temsirolimussunitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00417677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00417677.